These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 31764258

  • 21. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention.
    Reidy M, Gardiner E, Pretorius C, Glaubius R, Torjesen K, Kripke K.
    PLoS One; 2019; 14(6):e0218710. PubMed ID: 31242240
    [Abstract] [Full Text] [Related]

  • 22. Preferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in Gauteng Province, South Africa: a protocol for a discrete choice experiment.
    Quaife M, Eakle R, Cabrera M, Vickerman P, Tsepe M, Cianci F, Delany-Moretlwe S, Terris-Prestholt F.
    BMJ Open; 2016 Jun 27; 6(6):e010682. PubMed ID: 27354071
    [Abstract] [Full Text] [Related]

  • 23. "We are not the same": African women's view of multipurpose prevention products in the TRIO clinical study.
    Shapley-Quinn MK, Manenzhe KN, Agot K, Minnis AM, van der Straten A.
    Int J Womens Health; 2019 Jun 27; 11():97-107. PubMed ID: 30799959
    [Abstract] [Full Text] [Related]

  • 24. HIV prevention is not all about HIV - using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection.
    Vickerman P, Quaife M, Kilbourne-Brook M, Mvundura M, Eakle R, Terris-Prestholt F.
    BMC Infect Dis; 2020 Sep 25; 20(1):704. PubMed ID: 32977745
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Incorporating end-users' voices into the development of an implant for HIV prevention: a discrete choice experiment in South Africa and Zimbabwe.
    Browne EN, Manenzhe K, Makoni W, Nkomo S, Mahaka I, Ahmed K, Shapley-Quinn MK, Marton T, Luecke E, Johnson L, van der Straten A, Minnis AM.
    BMC Womens Health; 2023 Feb 10; 23(1):58. PubMed ID: 36765358
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Perspectives on biomedical HIV prevention options among women who inject drugs in Kenya.
    Bazzi AR, Yotebieng KA, Agot K, Rota G, Syvertsen JL.
    AIDS Care; 2018 Mar 10; 30(3):343-346. PubMed ID: 28780885
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results.
    Montgomery ET, Stadler J, Naidoo S, Katz AWK, Laborde N, Garcia M, Reddy K, Mansoor LE, Etima J, Zimba C, Chitukuta M, Soto-Torres L.
    AIDS; 2018 Jul 17; 32(11):1517-1525. PubMed ID: 29957723
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.